Terns Pharmaceuticals, Inc.

NasdaqGS:TERN Stock Report

Market Cap: US$4.3b

Terns Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TERN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Jan 26SellUS$7,920Emil KuriakoseIndividual200US$39.60
02 Jan 26SellUS$36,632Emil KuriakoseIndividual955US$38.36
01 Oct 25SellUS$7,407Emil KuriakoseIndividual944US$7.85
01 Jul 25SellUS$3,640Emil KuriakoseIndividual853US$4.27
27 Jun 25BuyUS$39,283Andrew GengosIndividual10,000US$3.93
25 Jun 25BuyUS$90,230Amy BurroughsIndividual23,314US$3.87
16 Jun 25BuyUS$57,083Andrew GengosIndividual15,000US$3.95
01 Apr 25SellUS$2,366Emil KuriakoseIndividual952US$2.49

Insider Trading Volume

Insider Buying: TERN insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of TERN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders340,1400.286%
Hedge Funds5,550,0004.67%
Institutions113,043,37995%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.1%.

Top Shareholders

Top 25 shareholders own 71.81% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.53%
BlackRock, Inc.
8,193,935US$324.3m47.6%no data
7.23%
Morgan Stanley
7,868,431US$311.4m4.31%0.03%
5.1%
Adage Capital Management, L.P.
5,550,000US$219.7m40.9%0.33%
5.08%
The Vanguard Group, Inc.
5,523,948US$218.6m21.1%no data
4.14%
Vestal Point Capital, LP
4,500,000US$178.1m0%6.6%
4%
Avoro Capital Advisors LLC
4,350,000US$172.2m0%1.68%
3.72%
Vivo Capital, LLC
4,042,143US$160.0m-24.4%9.35%
3.11%
Janus Henderson Group plc
3,379,569US$133.8m0%0.05%
2.91%
Citadel Advisors LLC
3,166,642US$125.3m99.2%0.09%
2.8%
Capitolis Advisors LLC
3,045,200US$120.5m0%0.73%
2.55%
Holocene Advisors, LP
2,775,493US$109.9m0%0.23%
2.5%
Franklin Resources, Inc.
2,715,034US$107.5m113%0.03%
2.49%
Lord, Abbett & Co. LLC
2,712,399US$107.4m19,300%0.31%
1.98%
OrbiMed Advisors LLC
2,153,300US$85.2m-71.5%1.17%
1.93%
Geode Capital Management, LLC
2,096,642US$83.0m22.3%no data
1.74%
Columbia Management Investment Advisers, LLC
1,894,381US$75.0m0%0.01%
1.63%
State Street Global Advisors, Inc.
1,775,922US$70.3m10.6%no data
1.61%
Acorn Bioventures
1,746,264US$69.1m-11.4%23.92%
1.57%
Nearwater Capital Markets, Limited
1,704,800US$67.5m0%1.1%
1.45%
Pictet Asset Management Limited
1,577,116US$62.4m42.8%0.04%
1.44%
JP Morgan Asset Management
1,571,025US$62.2m162%0.01%
1.39%
Healthcare of Ontario Pension Plan Trust Fund
1,515,400US$60.0m0%0.1%
1.36%
Commodore Capital LP
1,475,000US$58.4m-74.1%3.37%
1.29%
The Toronto-Dominion Bank
1,400,802US$55.4m0%0.06%
1.27%
Woodline Partners LP
1,377,283US$54.5m372%0.21%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/18 08:22
End of Day Share Price 2026/02/18 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Terns Pharmaceuticals, Inc. is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Etzer DaroutBarclays
Etzer DaroutBMO Capital Markets Equity Research
Evan SeigermanBMO Capital Markets Equity Research